Background: Contrast media (CM) are among the most widely used medications in the world. Our objective was to estimate the severity and incidence of adverse reactions to MC, first administered in hospitalized patients. Methods: We prospectively studied 99 patients requiring computed tomography (CT) enhanced with MC. Immediate adverse reactions were identified by direct questioning and/or physical examination after administration of iodinated CM nonionic low osmolarity. Additionally, blood pressure, heart rate, oxygen saturation, serum creatinine and total count of eosinophils were measured before and after the procedure. Results: Mean age of patients was 50.4 6 20.2 years, women were 52. The occurrence of immediate adverse reactions and no immediate observed were 26.3 and 10.1% respectively. Eighteen (69.2%) of the immediate reactions were mild, 6 (23.1%) moderate and 2 (7.7%) severe (both developed symptomatic arrhythmias). The most common manifestations were warmth, nausea and itching, nephrotoxicity was observed in 5.1% of patients and eosinophilia in 3.1%. No skin reactions documented. Median serum creatinine before and after the procedure not observed significant difference (P ¼ 0.130), instead the total number of eosinophils did show difference (P , 0.001).
Clínica Lepoldo Aguerrevere, Caracas, Venezuela. Background: Type I Allergy had been defined as an adverse immunologic reaction mediated by IgE that occurs after a repeated exposure to specific protein. The prevalence of the allergies has increased considerably in the past 20 years, thus increasing the need of study the response to several allergens. The objective was evaluate the frequency of foods and respiratory allergens sensitization in patients referred to Corpodiagnostica Laboratory (Caracas, Venezuela, ISO 9001:2008 certified laboratory) in the period that correspond from January 2010 and to July 2011. Methods: There were a total of 2.445 patients with a request of specific IgE against some foods and aero-allergens. The sample was divided in groups according the age and sex. We measured the specific IgE to each patient by the in vitro RIDA Allergy-screen immunoblot method (r-biopharm, Germany). Results: The frequency of sensitization to aeroallergens were 41, 48% in 2010 (the most frequent were dust mites in the fallowing order: Dermatophagoides pteronissinus, D. farinae and Blomia tropicalis), and 51, 20% in 2011, being the frequent: D. farinae, B. tropicalis and D. pteronissinus. In the case of food allergens the frequency of sensitization were 25, 99% in 2010 and 36, 47% in 2011. Conclusions: In Venezuela the most frequent aero-allergens during the whole period were the dust mites, unlike other countries with established weather seasons, by another hand for food allergens the most frequent were milk and cheese. In most patients, the specific concentration of IgE type antibodies against the aero-allergens and food proteins were low, however, we observed that for some allergens such as dust mites and seafood the concentration achieved were higher. The food allergies could predisposes to a further respiratory complication, therefore it is important the diagnosis of this kind of reactions. Background: The egg allergen ovomucoid (Gal d 1) is conformationally stabilized by 9 disulfide bonds. However, patients with persistent egg-allergy have more IgE against sequential than conformational epitopes of ovomucoid. We investigated whether natural or added food compounds may cause reduction of disulfide bonds and linearization of ovomucoid. Methods: Reduced ovomucoid in raw eggwhite was detected using a fluorescence-labeled alkylation probe. The common anti-oxidants glutathione and cystein were used for in vitro linearization and effects were monitored by CD-spectrometry. Egg-allergic patients were tested serologically (n ¼ 19) and by skin prick test (n ¼ 9) for IgE against native and linearized ovomucoid and optionally its cooked state. Results: Linearized ovomucoid could be detected in native eggwhite. Glutathione and cystein treatments, but not cooking linearized ovomucoid, as confirmed by CD-spectrometry. In Western Blot involving cooking more patients had IgE against reduced than native ovomucoid. In ELISA, most IgE was found against raw and native ovomucoid. Cooking of native ovomucoid significantly decreased, whereas cooking of previously linearized ovomucoid enhanced IgEbinding. In skin prick test 5/9 patients reacted with linearized ovomucoid. Conclusions: Linearized ovomucoid is present in natural eggwhite. Glutathione which is occurring naturally but is also frequently used as structure improving additive in processed food is partly responsible. Additional cooking of linearized ovomucoid increases IgE-reactivity in patients with persistent eggallergy in vitro and in skin prick tests. Our data provide evidence that reduction is a novel principle which contributes to the allergenicity of food. This may be relevant for new allergies to modern processed food. Background: Classical allergen-specific immunotherapy (SIT), using subcutaneous injections with food extracts, may be effective but dangerous due to anaphylactic side-effects. The FAST project (Food Allergy Specific Immunotherapy) aims at the development of safe and effective treatment of food allergies, targeting persistent and severe allergy to fish (cod) and fruit (peach). Both are caused by a single major allergen, parvalbumin (Cyp c 1) and lipid transfer protein (Pru p 3), respectively. FAST will apply hypoallergenic recombinant major allergens for SIT. Methods: Two approaches were evaluated for achieving hypo-allergenicity, i.e. site-directed mutagenesis and chemical modification. Wildtype (wt) natural and recombinant allergens and the hypo-allergens were extensively purified and characterized physico-chemically. Their stability was tested and allergenicity was compared by CAP-inhibition and histamine release experiments while immunogenicity was tested in T-cell proliferation experiments and rabbit and mice immunizations. Results: For Cyp c 1, the mutant without calcium-binding site showed up to a 1000 times reduced allergenicity, while secondary fold and immunogenicity (tested in human PBMC stimulations and by immunization of laboratory animals) were retained. Chemically modified Cyp c 1 demonstrated a reduced capacity to stimulate T-cells and showed less immunogenicity in rabbits. The calcium-binding mutant has been produced under GMP conditions.For Pru p 3, 5 potential hypoallergens were compared. The allergenicity was reduced to a similar extent (w1000-fold) for both variants in which disulfide bridges were disrupted, i.e. either by mutagenesis or by reduction/alkylation. The modification resulted in loss of alpha-helical secondary structure. However, unexpectedly, the immunogenicity was also significantly lowered/absent. Conclusions: For the Cyp c 1 calcium-binding mutant we are preparing to enter Phase I clinical trials. For Pru p 3, we need to evaluate new molecules to generate a hypoallergenic mutant that retains immunogenicity.
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IFN-ã Induces Milk Allergen-Specific IL-10-Producing Regulatory B Cells in Non-IGE Mediated Milk Allergy
Jae Ho Lee, Sr, MD, PhD. Department of Pediatrics, School of Medicine, Chungnam National University, Taejeon, South Korea. Background: Tolerance induction is one of the most important concerns in the treatment of allergies and autoimmune diseases. L-10-producing regulatory B cells (Br1s) seem to have a role in immune tolerance to food allergens. Oral immunotherapy using IFN-gamma has been successful for food allergy treatmen. We were to investigate the effects of IFN-gamma on allergen-specific Br1 responses in milk allergy patients and milk-tolerant subjects to evaluate the mmunomodulatory effects of IFN-gamma on Br1 cell responses. Methods: The 6 milk allergy patients and 8 milk-tolerant subjects were selected by DBPCFC and clinical characteristics. The PBMCs were stimulated in vitro with casein only, IFN-gamma with casein, or without any stimulant. And the CD19(1) CD5(1) B cells were gated and the expression of IL-10 and Annexin V binding were subsequently analysed. Results: In milk allergy group, the Br1 fraction decreased from 24.4 to 15.0% (P ¼ 0.002) after casein stimulation and it was recovered to 22.6% in the presence of IFN-gamma (P ¼ 0.006). In milk-tolerant group, the Br1 fraction increased from 9.4 to 17.1% after casein stimulation (P ¼ 0.014) and to 15.7% after IFNgamma were added (P ¼ 0.066). The proportion of apoptotic Br1s among CD5 (1) B cells decreased from 16.5 to 8.1% with casein (P ¼ 0.003) and to 11.8% with IFN-gamma and casein (P ¼ 0.141) in milk allergy group, while in milktolerant group, the proportion of apoptotic Br1 increased from 8.2 to 15.0% after casein stimulation (P ¼ 0.014), but was unchanged by casein with IFN-gamma. Conclusions: Allergen-specific Br1 responses and the apoptotic Br1 fraction were induced by IFN-gamma in milk allergy patients, but were not changed in milk-tolerant subjects. Finally IFN-gamma induced allergen-specific Br1 responses and immune tolerance to specific allergens in milk allergy patients. Department of Pediatrics, Tokyo Kousei-nenkin Hospital, Tokyo, Japan. Background: Food allergy primarily causes anaphylaxis in children. Food such as egg, cow milk, wheat and peanut are common allergen in Japan. Methods: In this study total IgE, IgE RAST value and prick test are evaluated to monitor the efficacy outcome in wheat or hen's egg-allergy infants treated with slow specific oral tolerance induction (sSOTI) therapy. Results: The 3 infants suffered from IgE-mediated food allergy (wheat: 2 years 8 or 10 months old boy [threshold dose 25 g] and girl [0.7 g], hen's egg: 4 years 9 months old girl [1.8 g]), diagnosed, by food challenge, as allergy to wheat and egg. Then, the patients were treated with sSOTI either with hard-boiled egg or wheat noodle at home daily starting with 0.1 g, respectively, increased to a dose of 60 g egg or 100 g wheat, every one to 2 weeks in double dose of the weight, until tolerance was taken on. The daily maintenance dose was 10 g for each food. Four weeks later confirmed was evolution of tolerance by re-challenge. The safety and efficacy of the sSOTI therapy were confirmed in these infants. Total IgE levels were increased after SOTI therapy whereas IgE RAST value to causative antigen such as egg and wheat, contrastingly reduced. IgE RAST value to some other food as cow's milk, reduced coincidently by bystander inhibition. IgE RAST value to a food, negative in prick test, was increased again, whereas that to a food, positive in the test, was carried on. Conclusions: The results indicates that sSOTI therapy induced causative antigen-specific IgE-mediated tolerance in children with wheat or egg allergy, and the set of total IgE increased, reduced IgE RAST value and positive prick test was of service to evaluate evolution of tolerance in slow SOTI therapy. 
